REQUEST A DEMO
Total
USD $0.00
Search more companies

Fenixpharma S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Health and Personal Care Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores
Full name: Fenixpharma S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Fenixpharma S.A.S. is an enterprise based in Ecuador. Its main office is in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Fenixpharma S.A.S. was incorporated on June 08, 2022. 11 (2024) employees currently work for Fenixpharma S.A.S.. In 2024, the company reported a net sales revenue increase of 28.52%. During that time, Fenixpharma S.A.S.’s total assets grew by 2.63%. The net profit margin of Fenixpharma S.A.S. decreased by 60.31% in 2024.

Headquarters
Av. Amazonas, N31-62
Quito; Pichincha;

Contact Details: Purchase the Fenixpharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Fenixpharma S.A.S. report to view the information.
Registered Capital:
Purchase the Fenixpharma S.A.S. report to view the information.
Financial Auditors:
Purchase the Fenixpharma S.A.S. report to view the information.
Incorporation Date:
June 08, 2022
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Fenixpharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
28.52%
Total operating revenue
28.52%
Operating profit (EBIT)
-1336.79%
EBITDA
-1342.34%
Net Profit (Loss) for the Period
-1062.23%
Total Assets
2.63%
Total Equity
N/A
Operating Profit Margin (ROS)
-58.56%
Net Profit Margin
-60.31%
Return on Equity (ROE)
N/A
Debt/Equity
N/A
Quick Ratio
-1.1%
Cash Ratio
-0.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?